Study of Baduanjin Eight-Silken-Movement Exercise Program Combined With Usual Medication for Adults With Chronic Heart Failure in Guangzhou, China
Led by Guangdong Provincial Hospital of Traditional Chinese Medicine · Updated on 2025-05-18
150
Participants Needed
1
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Chronic heart failure CHF is a significant and growing health issue that creates economic challenges for society. Researchers are evaluating a safe, equipment-free, low-cost exercise-based cardiac rehabilitation program called BESMILE-HF, which centers on Baduanjin exercise, a traditional Chinese form of exercise. This program aims to support patients with CHF in China by combining exercise with education, evaluation, and consultation. The study is a randomized controlled trial developed by Guangdong Provincial Hospital of Traditional Chinese Medicine to assess the programs effectiveness and acceptability for CHF patients.
Participants in the study will continue receiving typical Western medications for chronic heart failure according to national guidelines. In addition to standard care, one group will participate in the BESMILE-HF program, which includes Baduanjin exercise, evaluations of exercise capacity and clinical conditions, consultations on exercise prescriptions and symptom management during exercise, education about CHF and exercise, and strategies to support adherence. The control group will receive only usual medications without exercise-based rehabilitation.
During the study, participants peak oxygen uptake peak VO2 and quality of life measured by the Minnesota Living with Heart Failure Questionnaire will be assessed at the start and after 12 weeks. Additional tests and questionnaires, such as the 6-minute walk test, timed up and go test, self-efficacy scales, heart function imaging, blood biomarkers, and mood assessments, will be conducted at several points over the 12 weeks. The study measures how the program affects exercise capacity, heart function, symptoms, mental health, and quality of life. The total participation lasts 12 weeks with multiple evaluations to monitor progress and safety.
CONDITIONS
Brief Title
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
Research Team
W
Weihui Lu
X
Xiankun Chen
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Aged 18 years or above
Diagnosed with chronic heart failure
Clinically stable with symptoms and signs unchanged for at least 1 month
New York Heart Association (NYHA) functional class II or III
You will not qualify if you...
Contraindications to cardiopulmonary test
Contraindications to exercise training
Serious acute or chronic organic disease or mental disorders
Cardiac surgery, cardiac resynchronization therapy, or intracardiac defibrillation within the previous 3 months
Cardiac arrest within 1 year
History of peripartum cardiomyopathy, hyperthyroid heart disease, or primary pulmonary hypertension
Inability to perform a bicycle stress test
Severe cognitive dysfunction preventing informed consent or understanding of exercise
Current regular practice of Baduanjin or participation in a conventional cardiac rehabilitation program
Current participation in another clinical trial
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 12 weeks
Participants receive either the BESMILE-HF exercise-based cardiac rehabilitation program in addition to usual medications, or usual medications alone, to manage chronic heart failure.
Baseline visit and weekly visits for assessments up to 12 weeks
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Phase 2 Study of 18F-mFBG PET Imaging
for Heart Failure Patients with Ischemic Cardiomyopathy
and Implantable Cardioverter-Defibrillators
Post-Discharge Counseling and Phone Follow-Up to Reduce Heart Failure Readmissions at Komfo Anokye Teaching Hospital
Myocardial Energetic Profiling Using 31P Magnetic Resonance Spectroscopy
and Prognostic Assessment Across Heart Failure and Cardiomyopathy Types
3D Imaging Study of Right Heart Function During Mechanical Pump Placement for Heart Failure
Evaluating Cardiac Fibrosis in Heart Failure Using 68Ga-FAPI PETCT Compared to MRI
A Pilot Study in Patients with HFrEF and HFpEF
Study of Vascular Function and Exercise Effects in Aging and Cardiovascular Diseases Including COPD and Pulmonary Hypertension
A Phase I Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Effects of Oral Doses of HRS-5765 in Healthy Adults Aged 18 to 65
Phase I Study Evaluating Safety and Pharmacokinetics of Single and Multiple Oral Doses of HRS-7156 in Healthy Adults
Optimizing Heart Failure and Chronic Kidney Disease Treatment in Elderly Patients Using Sodium Zirconium Cyclosilicate to Manage Potassium Levels
Danish Study Testing Coenzyme Q10 and Selenium Supplements to Reduce Hospitalization and Death in Heart Failure Patients
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effect of an exercise-based cardiac rehabilitation program "Baduanjin Eight-Silken-Movements with self-efficacy building" for heart failure (BESMILE-HF study): study protocol for a randomized controlled trial.